Diversity in the context of real-world research refers to the inclusion of individuals from different backgrounds, including but not limited to race, ethnicity, gender, age, sexual orientation, socioeconomic status, and geographic location. It is important to ensure diversity in research because it can provide a more comprehensive understanding of health and healthcare outcomes, as well as enable the development of interventions that are effective for all populations.
In the past, research has often focused on populations that are easier to access, which has led to underrepresentation of certain groups in research studies. This lack of diversity can result in biased and incomplete research findings that do not accurately reflect the experiences and health outcomes of all populations.
Therefore, it is crucial for real-world research to include diverse populations to ensure that research findings can be generalized to all groups. This can help to identify health disparities, understand the root causes of these disparities, and develop interventions that are effective for all populations.
In summary, diversity in real-world research means including individuals from diverse backgrounds to ensure that research findings are inclusive, representative, and generalizable to all populations. By doing so, research can more effectively identify and address health disparities and improve health outcomes for all individuals.
Share this story...
Real World Evidence (RWE) 101 – Patient Retention
RWE 101 - Patient Retention Long-term Real-World Evidence (RWE) studies face significant challenges when it comes to patient retention, for several reasons:[1] Time Commitment: Participants in RWE studies are [...]
Real World Evidence (RWE) 101 – Patient Recruitment
RWE 101 - Patient Recruitment Real-world evidence (RWE) is health care information derived from real-world data (RWD). It can be generated through various study designs or analyses, including pragmatic [...]
Real World Evidence (RWE) 101 – HARPER
RWE 101 - HARPER Regulatory agencies, health technology assessors, and payers are increasingly interested in studies that make use of real-world data to inform regulatory and other policy or [...]
Real World Evidence (RWE) 101 – STaRT-RWE
RWE 101 - STaRT-RWE START-RWE (Structured Template for Planning and Reporting on the Implementation of Real World Evidence Studies) was developed to address the need for improved transparency and [...]
Real World Evidence (RWE) 101 – Protocol Design and ISPE GPP
RWE 101 - Protocol Design and ISPE GPP The International Society for Pharmacoepidemiology (ISPE) Guidelines for Good Pharmacoepidemiology Practices (GPP) are a set of best practices for the conduct [...]
Real World Evidence (RWE) 101 – Protocol Design and Scientific Best Practices
RWE 101 - Protocol Design and Scientific Best Practices Designing a robust Real-World Evidence (RWE) study is crucial for generating reliable and valid insights that are acceptable to regulators. [...]







